Schilling T, Bekeredjian R, Haverich A, Katus H A
Klinik für Herz-, Thorax-, Transplantations- und Gefässchirurgie, Medizinische Hochschule, Carl-Neuberg-Strasse 1, 30625, Hannover, Deutschland.
Chirurg. 2010 Dec;81(12):1066-72. doi: 10.1007/s00104-010-1988-1.
Increasingly complex techniques in cardiovascular medicine lead to a competitive partnership between cardiology and cardiac surgery. Common challenges will arise in the fields of coronary heart disease, heart valves, heart failure and rhythm therapy. For instance, coronary revascularization in acute myocardial infarction is no longer considered to exclusively be an interventional option. In comparison, the implantation of heart valves is increasingly carried out by cardiologists using interventional techniques. The latest designs of sutureless valves try to combine the benefits of conventional and transcatheter heart valves. Heart failure is the most common reason for hospital admission and thus an important therapeutic target for cardiology and cardiac surgery. New approaches in diagnostics, heart assist devices and cellular therapy meet this challenge.
In the future only a sensitive and transparent collaboration across transsectoral borders will offer optimal therapy in cardiovascular medicine.
心血管医学中日益复杂的技术导致心脏病学与心脏外科之间形成了一种竞争性的伙伴关系。在冠心病、心脏瓣膜、心力衰竭和节律治疗领域将出现共同的挑战。例如，急性心肌梗死的冠状动脉血运重建不再被认为仅仅是一种介入选择。相比之下，心脏瓣膜植入越来越多地由心脏病学家采用介入技术进行。无缝合瓣膜的最新设计试图将传统心脏瓣膜和经导管心脏瓣膜的优点结合起来。心力衰竭是住院的最常见原因，因此是心脏病学和心脏外科的一个重要治疗靶点。诊断、心脏辅助装置和细胞治疗方面的新方法应对了这一挑战。
未来，只有跨部门边界的敏感且透明的合作才能在心血管医学中提供最佳治疗。
